treatment
Interviews and expert commentary tagged “treatment” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Medicine
In this edition: 1. Training In Depression And Suicide: Need For Change? Stan Kutcher, Dalhousie University, Nova Scotia 2. Suicide Paradox Explained: Australian National Strategy Barry Nurcombe, Prin
Never Too Old For Hypertension Treatment!
Nigel Beckett Nick Boon Nigel Beckett, Imperial College, London COMMENT: Nick Boon, British Cardiovascular Society, London Even very old patients benefit greatly if you treat their hypertension. This
Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors
Silvia Novello SILVIA NOVELLO, University of Turin Future improvements in drug treatment of lung cancer may be made by inhibiting more than one tyrosine kinase simultaneously. So said Silvia Novello w
Audio Journal of Oncology in Advance – March 15th, 2008
Volume 16 Number 6 (March 15th, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) American Society of Hematology Annual Meeting (December 8-11, 2007
Audio Journal of Oncology in Advance – March 1st, 2008
Volume 16 Number 5 (March 1st, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) Gastrointestinal Cancers Symposium (January 25-27, 2008, Orlando) A
“Total Therapy” Possible Cure For Multiple Myeloma?
Bart Barlogie Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 BART BARLOGIE, University of Arkansas, Little Rock A treatment known as “total therapy
Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer
David Cunningham REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 DAVID CUNNINGHAM, Royal Marsden Hospital, London The oral agent capeticabine
Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
Peter Tyrer REFERENCE: Lancet 371:57 January 5, 2008 PETER TYRER, Imperial College, W6 8RP London A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients
Reduce Maternal Deaths!
Ann Starrs Carine Ronsmans REFERENCE: The Lancet’s Women Deliver Press Conference, London, 11th October 2007 CARINE RONSMANS, London School of Hygiene and Tropical Medicine VERONIQUE FILIPPI, Lo
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona CO
Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed?
London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007
Virus Plus Cytokine Fight Primary and Metastatic Cancer
Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b
Tuberculosis: Non-Adherence to Treatment is a Major Obstacle to Therapy Success
Simon Lewin REFERENCE: PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238 SIMON LEWIN, London School of Hygiene and Tropical Medicine Non-adherence is a big factor reducing the efficacy of tuberculo
Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen
Mitchell Shiffman REFERENCE: N Engl J Med 2007;357:124-34 MITCHELL SHIFFMAN, Virginia Commonwealth University, Richmond Standard anti-viral therapy for Hepatitis C needs to be used to the full duratio
Statins Protect Heart Patients from Sepsis
Donald Redelmeier, University of Toronto Abstract: Lancet 2006; 367:413 Treatment with the lipid lowering agents statins reduced the incidence of sepsis among a large group of patients with cardiovasc